Comparison of individual patient data from real-world experience with the ADAURA study for resected stage IB-IIIA EGFR-mutated non-small cell lung cancer

被引：0
|
作者：
Jung, Hyun Ae
Lee, Junho
Park, Boram
Park, Sehhoon
Sun, Jong-Mu
Lee, Se-Hoon
Ahn, Jin Seok
Ahn, Myung-Ju
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3830
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3830
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
    Molife, Cliff
    Winfree, Katherine B.
    Bailey, Hollie
    D'yachkova, Yulia
    Forshaw, Cameron
    Kim, Sangmi
    Taipale, Kaisa-Leena
    Puri, Tarun
    ADVANCES IN THERAPY, 2023, 40 (07) : 3135 - 3168
  • [22] A real-world study of Afatinib plus ramucirumab in treatment-naive, EGFR-mutated, non-small cell lung cancer
    Huang, Chun-Yao
    Huang, Hui-Li
    Lan, Chou-Chin
    Huang, Yi-Chih
    Wu, Yao-Kuang
    BMC CANCER, 2023, 23 (01)
  • [23] NEUROLOGICAL EVOLUTION OF A PATIENT WITH EGFR-MUTATED NON-SMALL CELL LUNG CANCER
    Ianza, A.
    Dicorato, A.
    Guglielmi, A.
    Orlando, V.
    Furlanis, G.
    Curro, F.
    CHEST, 2022, 161 (06) : 333A - 333A
  • [24] Preoperative liquid biopsy for EGFR-mutated detection at diagnostic in early-stage non-small cell lung cancer: real-world experience of a single centre
    Bontoux, Christophe
    Benzaquen, Jonathan
    Taly, Valerie
    Baures, Aurelia
    Allegra, Maryline
    Lacoux, Caroline
    Tanga, Virginie
    Rignol, Guylene
    Berthet, Jean-Philippe
    Marquette, Charles-Hugo
    Lespinet-Fabre, Virginie
    Bordone, Olivier
    Goffinet, Samantha
    Ilie, Marius
    Hofman, Veronique
    Hofman, Paul
    JOURNAL OF CLINICAL PATHOLOGY, 2025,
  • [25] Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010)
    Kenmotsu, Hirotsugu
    Sugawara, Shunichi
    Watanabe, Yasutaka
    Saito, Haruhiro
    Okada, Morihito
    Chen-Yoshikawa, Toyofumi Fengshi
    Ohe, Yuichiro
    Nishio, Wataru
    Nakagawa, Shizuka
    Nagao, Haruka
    CANCER SCIENCE, 2022, 113 (12) : 4327 - 4338
  • [26] High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, Haiyang
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    Yang, Sen
    He, Zhen
    Mo, Yuqing
    Zhang, Cuicui
    Wang, Qiming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer
    Davidov, Mikhail I.
    Polotzky, Boris E.
    Marenich, Aleksander F.
    Orlov, Sergey V.
    Lazarev, Aleksander F.
    Skryabina, Lyudmila S.
    Pavlushkov, Eugeniy V.
    Semenchenya, Vladimir A.
    Brichkova, Olga Y.
    Karaseva, Vera V.
    ANTI-CANCER DRUGS, 2011, 22 (06) : 569 - 575
  • [28] Leptomeningeal carcinomatosis from EGFR-mutated non-small cell lung cancer
    Iuchi, T.
    Shingyoji, M.
    Setoguchi, T.
    Yoshida, Y.
    Ashinuma, H.
    Hasegawa, Y.
    Sakaida, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] A Patient With Newly Diagnosed, Advanced EGFR-Mutated Non-Small Cell Lung Cancer
    Lara-Mejia, Luis
    Sanchez-Reyes, Roberto
    Aviles-Salas, Alejandro
    Arrieta-Rodriguez, Oscar
    ONCOLOGY-NEW YORK, 2020, 34 (01): : 21 - 27
  • [30] Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
    Yu, Xiaoqing
    Sheng, Jiamin
    Pan, Guoqiang
    Fan, Yun
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1121 - 1128
12345